Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Genesis Pre-Seed Fund is a $15 million venture capital fund established by the University of Melbourne in partnership with Breakthrough Victoria. Launched in 2023, the fund is designed to bridge the 'valley of death' for early-stage startups emerging from the University of Melbourne's research ecosystem. It provides pre-seed capital, expertise, and mentoring to researchers, students, and alumni, with a strong focus on deep tech sectors such as life sciences, therapeutics, medical devices, and agtech. The fund aims to accelerate the translation of world-class research into commercially viable products and services that address global challenges.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genesis Pre-Seed Fund.